传统结肠镜与第二代远端附件帽结肠镜的腺瘤漏诊率和腺瘤检出率比较:一项多中心、随机、背靠背试验
这项多中心、国际、背靠背、随机结肠镜试验纳入40至75岁患者,比较Endocuff Vision辅助结肠镜(EVC)与传统结肠镜(CC)的腺瘤检出率(ADR)和腺瘤漏诊率(AMR)。结果显示EVC未显著改善ADR(41.1% vs 35.5%,P=.125),但将AMR降低11.7%(29.6% vs 17.9%,P=.049)。结论认为EVC降低漏诊腺瘤风险但未显著提高ADR,传统结肠镜仍漏诊25%的腺瘤,其中仅3.7%的漏诊病变具有进展期病理特征。
要点
- EVC未显著改善腺瘤检出率(41.1% vs 35.5%,P=.125)。
- EVC将腺瘤漏诊率降低11.7%(29.6% vs 17.9%,P=.049)。
- 传统结肠镜仍漏诊25%的腺瘤,仅3.7%漏诊病变有进展期特征。
核心结论
- EVC降低漏诊腺瘤的风险,但未显著改善腺瘤检出率。
- 传统结肠镜仍漏诊25%的腺瘤,与25年前报告的漏诊率无差异;令人欣慰的是,这些漏诊病变中仅3.7%具有进展期病理特征。
研究设计与样本
- 多中心、国际、背靠背、随机结肠镜试验,在10家医院纳入40至75岁因非免疫化学粪便隐血试验筛查、监测或诊断性结肠镜转诊的患者。
- 共随机717例患者,其中661例(92.2%)完成1次背靠背结肠镜,646例(90.1%)完成2次背靠背结肠镜。
- 患者随机分为4组:第1组2次CC;第2组CC后EVC;第3组EVC后CC;第4组2次EVC。
- 主要结局包括腺瘤检出率(ADR)和腺瘤漏诊率(AMR)。
主要发现
- EVC与CC相比未显著改善ADR(41.1% [95%CI 36.1-46.3] vs 35.5% [95%CI 30.7-40.6],P=.125)。
- EVC将AMR降低11.7%(29.6% [95%CI 23.6-36.5] vs 17.9% [95%CI 12.5-23.5],P=.049)。
- 2次CC与2次EVC的AMR无显著差异(25.9% [95%CI 19.3-33.9] vs 18.8% [95%CI 13.9-24.8],P=.172)。
- 第一次操作中漏诊的息肉仅3.7%具有进展期病理特征。
- 影响腺瘤漏诊风险的因素包括年龄(P=.002)、波士顿肠道准备量表(P=.008)和结肠镜检查所在地区(P<.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Endocuff Vision (Olympus Europe, Hamburg, Germany) has been designed to enhance mucosal visualization, thereby improving detection of (pre-)malignant colorectal lesions. This multicenter, international, back-to-back, randomized colonoscopy trial compared the adenoma detection rate (ADR) and adenoma miss rate (AMR) between Endocuff Vision-assisted colonoscopy (EVC) and conventional colonoscopy (CC). METHODS: Patients aged 40 to 75 years referred for non-immunochemical fecal occult blood test-based screening, surveillance, or diagnostic colonoscopy were included at 10 hospitals and randomized into 4 groups: group 1, 2 × CC; group 2, CC followed by EVC; group 3, EVC followed by CC; and group 4, 2 × EVC. Primary outcomes included ADR and AMR. RESULTS: A total of 717 patients were randomized, of whom 661 patients (92.2%) had 1 and 646 (90.1%) patients had 2 completed back-to-back colonoscopies. EVC did not significantly improve ADR compared to CC (41.1%; [95% confidence interval (CI), 36.1-46.3] vs 35.5% [95% CI, 30.7-40.6], respectively; P = .125), but EVC did reduce AMR by 11.7% (29.6% [95% CI, 23.6-36.5] vs 17.9% [95% CI, 12.5-23.5], respectively; P = .049). AMR of 2 × CC compared to 2 × EVC was also not significantly different (25.9% [95% CI, 19.3-33.9] vs 18.8% [95% CI, 13.9-24.8], respectively; P = .172). Only 3.7% of the polyps missed during the first procedures had advanced pathologic features. Factors affecting risk of missing adenomas were age (P = .002), Boston Bowel Preparation Scale (P = .008), and region where colonoscopy was performed (P < .001). CONCLUSIONS: Our trial shows that EVC reduces the risk of missing adenomas but does not lead to a significantly improved ADR. Remarkably, 25% of adenomas are still missed during conventional colonoscopies, which is not different from miss rates reported 25 years ago; reassuringly, advanced features were only found in 3.7% of these missed lesions. (Clinical trial registration number: NCT03418948.).
引用
- van Keulen KE, Papanikolaou IS, Mak TWC, et al. Comparison of adenoma miss rate and adenoma detection rate between conventional colonoscopy and colonoscopy with second-generation distal attachment cuff: a multicenter, randomized, back-to-back trial. Gastrointest Endosc. 2023. PMID: 37993062. doi:10.1016/j.gie.2023.11.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。